LONDON/PARIS, July 28 (Reuters) - European stocks traded flat on Monday, with strong earnings updates from firms like Ryanair and spin-off talk from Reckitt Benckiser balancing concerns over the implications of new international sanctions on Russia.
Even more notable than Reckitt Benckiser ’s first-half results--3% like-for-like sales growth and 10 basis points of adjusted operating margin contraction to
LONDON, July 28 (Reuters) - Britain's top equity index crept higher on Monday, supported by solid results at consumer goods company Reckitt Benckiser which offset a slump at Aberdeen Asset...
Reckitt Benckiser ( OTCPK:RBGLY ) states that it will pursue a demerger of its pharmaceutical ..... a separate U.K.-listed company. The announcement follows the Reckitt Benckiser 's 7% drop in second-quarter revenue which fell to £2.3B from
LONDON, July 28 (Reuters) - Reckitt Benckiser plans to spin off its heroin-addiction treatment in the next 12 months as sales slide under pressure from rival copycat versions of the drug.
* Reckitt Benckiser leads risers after solid update, disposal plan
LONDON, July 28 (Reuters) - Reckitt Benckiser Group has not decided whether to maintain a stake in its shrinking pharmaceuticals business following a spin-off it expects to complete in the next 12 months.
German private equity firm Aurelius has agreed to buy Reckitt Benckiser 's ( OTCPK:RBGLY ) Scholl shoe business. The company is expecting the brand to expand internationally and maintain growth
FRANKFURT, July 21 (Reuters) - German private equity firm Aurelius said on Monday it is buying Reckitt Benckiser 's Scholl shoe business in its efforts to expand internationally, betting on the brand's growth potential.
July 21 (Reuters) - Aurelius AG : * Says to acquire Scholl's footwear division from Reckitt Benckiser Group plc * Says completion is scheduled for Q3 2014 * Source text for Eikon * Further company coverage